×

BioMarin CEO: Positive results for hemophilia treatment

8:38 AM ET Mon, 9 Jan 2017

CNBC's Meg Tirrell talks to BioMarin Pharmaceutical CEO Jean-Jacques Bienaime, about the outlook on the drug industry.